Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Interest Coverage Ratio (2020 - 2024)

Gyre Therapeutics has reported Interest Coverage Ratio over the past 9 years, most recently at 25.62 for Q1 2024.

  • Quarterly Interest Coverage Ratio rose 147.23% to 25.62 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 51.31 through Dec 2024, up 149.07% year-over-year, with the annual reading at 25.92 for FY2023, 486.95% down from the prior year.
  • Interest Coverage Ratio was 25.62 for Q1 2024 at Gyre Therapeutics, up from 10.36 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 25.62 in Q1 2024 and troughed at 2300.0 in Q3 2020.
  • The 3-year median for Interest Coverage Ratio is 183.23 (2020), against an average of 660.21.
  • The largest YoY upside for Interest Coverage Ratio was 147.23% in 2024 against a maximum downside of 147.23% in 2024.
  • A 3-year view of Interest Coverage Ratio shows it stood at 376.82 in 2020, then soared by 102.75% to 10.36 in 2023, then surged by 147.23% to 25.62 in 2024.
  • Per Business Quant, the three most recent readings for GYRE's Interest Coverage Ratio are 25.62 (Q1 2024), 10.36 (Q1 2023), and 376.82 (Q4 2020).